bpc-157 human clinical trial safety adverse events Five reasons adding peptides to the 503A bulk compounding lists may be more problematic than you realize – Partnership for Safe Medicines If BPC-157 worked as well
Description
Fowler MJ
It is not for injection alone

Label with the date and concentration, then refrigerate at 28 C (35.646.4 F) , shielded from light

The most common and convenient sites are the abdomen (a few inches to the side of the navel), the glutes, or the quadriceps
